Inivata is a Leader

in Liquid Biopsy
 
 
Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients

Our US Medicare-reimbursed lead product InVisionFirst-Lung is already transforming the lives of advanced NSCLC patients

Our Mission

We are transforming the lives of cancer patients and their families through the power of liquid biopsy

Our Technology

Contact Us

Latest News and Events

Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study

Inivata to provide ctDNA liquid biopsy using its InVisionFirst®-Lung test to analyze resistance in patients treated with lorlatinib ... Read More

Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression

Mihaela Aldea MD, PhD, Lizza Hendriks MD, PhD, Laura Mezquita MD, PhD, Cécile Jovelet PharmD, PhD, David Planchard MD, PhD, Edouard ... Read More

Liquid Biopsy for Precision Oncology Summit

Liquid Biopsy for Precision Oncology Summit

Event expiration date display - 10 - 12 FEB 2020

Location: San Diego Read More

Changing Lives

Patients are at the heart of everything we do.

Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives. 

This is the story of the first patient Inivata tested.

Transforming the lives of Cancer Patients and Their Families

As a dynamic and innovative company, we focus on the development of ground-breaking technology in a fast-paced and international setting.

Our team of talented and driven individuals work together to combine their energy and expertise in world-class research, product development and commercialization. Join us.

Thank you to @PMWCintl for an excellent conference last week. Standing room only for our company showcase session presented by our VP BD @antonynewton001. If you missed it, please contact us to find out more #liquidbiopsy #NSCLC #diagnostics #MRD #Immunotherapy

Lung Cancer #biomarker testing 1/2@WinshipAtEmory for #lungcancer @RamalingamMD @DrewMoghanaki @chrisdraft @NLCRTnews @AmySellsNorthGA @sespears @plh4lisa great job @JenniferCKing @MicheleZeh thank you @GO2Foundation for bringing Living Room 2 Atlanta‼️ https://m.youtube.com/watch?v=cw437E49g68&feature=youtu.be

ICYMI-Our recent poster with key collaborators
@AACR Advances in Liquid Biopsy Conference is available on our website: Role of circulating tumor DNA (ctDNA) from #LiquidBiopsy in Early Stage #NSCLC Resected Lung Tumor Investigation (LIBERTI) https://tinyurl.com/rusa2ol